- Tytuł:
- Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials)
- Autorzy:
- Deskryptory:
-
Autism
Pervasive Developmental Disorders
Children
Adolescents
Drug Therapy
Intervention
Symptoms (Individual Disorders)
Behavior Problems
Interpersonal Competence
Pharmacology - Źródło:
- Journal of Autism and Developmental Disorders. Aug 2021 51(8):2959-2972.
- Recenzowane naukowo:
- Y
- Page Count:
- 14
Czasopismo naukowe